Male urethral stricture disease is highly prevalent and difficult to treat due to potential complications. Minimally invasive treatments tend to have high recurrence rates, keeping urethroplasty as the gold standard. Collagenase Clostridium histolyticum (CCH) has been used in humans to treat fibrosis in a minimally invasive manner. Herein, we present the preliminary results from treatments of three males with urethral stricture as a feasibility and safety evaluation of the first-in-human CCH treatment for male urethral stricture disease.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566641 | PMC |
| http://dx.doi.org/10.7759/cureus.45051 | DOI Listing |
Publication Analysis
Top Keywords
urethral stricture
16
stricture disease
12
collagenase clostridium
8
clostridium histolyticum
8
male urethral
8
minimally invasive
8
safety xiaflex®
4
xiaflex® collagenase
4
histolyticum treatment
4
treatment adult
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!